SCHEMBL14438355

SCHEMBL14438355

CC(C)NC(C)c1ccc(-n2cccn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.51
▸ NOTUM Q6P988 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ PDE2A O00408 1/20 0.45
▸ ADAM17 P78536 10/20 0.43
▸ IDH1 O75874 1/20 0.43
▸ MAPT P10636 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNA10 Q9GZZ6 1/20 0.40
▸ CHRNA9 Q9UGM1 1/20 0.40
▸ ADAM10 O14672 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP7 P09237 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ MMP14 P50281 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8215541 0.81 NOTUM (0.55) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL5567481 0.81 NOTUM (0.55) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL10080953 0.81 POLB (0.65) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL16356412 0.80 KDM4E (0.54) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL29676438 0.79 PDE2A (0.54) POLBPDE2AADAM17ADAM10MMP2
SCHEMBL19368257 0.78 NOTUM (0.55) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL27821378 0.78 NOTUM (0.55) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL20004337 0.78 NOTUM (0.55) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL31023757 0.78 NOTUM (0.58) POLBNOTUMKDM4EALDH1A1MAPK1
SCHEMBL4341894 0.76 NOTUM (0.78) POLBNOTUMKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197522-A1 Dpp-iv inhibitors SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH (CH) 2007-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197522-A1 Dpp-iv inhibitors DPP7, DPP4, DPP3 POLB 4086/4885NOTUM 727/4885KDM4E 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback